location: Current position: Home >> Scientific Research >> Paper Publications

Efficient purification of active bufadienolides by a class separation method based on hydrophilic solid-phase extraction and reversed-phase high performance liquid chromatography

Hits:

Indexed by:期刊论文

Date of Publication:2014-08-25

Journal:JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Included Journals:SCIE、PubMed、Scopus

Volume:97

Page Number:54-64

ISSN No.:0731-7085

Key Words:Active bufadienolides; Hydrophilic solid-phase extraction; Class separation; Purification; Toad skin

Abstract:Traditional Chinese medicines (TCMs) have played a significant role in the process of discovering natural bioactive compounds, especially in anticancer therapeutics. However, the components of TCMs are complex mixtures with wide variation in polarity and content, which leads to inefficiency in the process of active compound discovery from TCMs. In this paper, the popular strategy of utilizing "pre-fractionated natural product libraries" has been improved by a new class separation approach to accelerate the process. As an example, the skin of Bufo bufo gargarizans Cantor, a well-known TCM, mainly contains two distinct bufadienolide classes: amino acid-conjugated bufadienolides (AACBs) and free form bufadienolides (AAUBs). We utilized hydrophilic interaction liquid chromatography solid-phase extraction (HILIC-SPE) to resolve the two types of bufadienolides, which co-eluted on C18 columns. By this strategy, twelve bufadienolides of the two types were purified via prep-HPLC from one active fraction, and eight of them were identified by H-1 NMR and C-13 NMR. These results indicated that the class separation method not only overcame the limited orthogonality in a 2D-RPLC x RPLC system but also accelerated the process of active compound discovery. (c) 2014 Elsevier B.V. All rights reserved.

Pre One:蟾毒配基磺酸化及基于自制串联固相萃取对磺酸化产物富集的研究

Next One:Binding affinity and efficacy-based pharmacophore modeling studies of retinoic acid receptor alpha agonists and virtual screening for potential agonists from NCI